The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
Tag: HER2 breast cancer
AACR 2023: Ohio State experts share new findings on immuno-oncology, ‘smart-drugs,’ obesity-related endometrial cancers and other research topics
New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.
Singapore scientists found a new way to improve treatment outcomes for breast cancer
Researchers from Cancer Science Institute of Singapore at NUS and A*STAR’s Genome Institute of Singapore as well as their collaborators have discovered the molecular pathway that interferes with breast cancer drugs, and found an additional drug that will reverse the effect. This discovery could give cancer patients more hope of overcoming the disease.